Logo image of EMX.CA

EMX ROYALTY CORP (EMX.CA) Stock Fundamental Analysis

TSX-V:EMX - TSX Venture Exchange - CA26873J1075 - Common Stock - Currency: CAD

2.52  -0.01 (-0.4%)

Fundamental Rating

4

EMX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 822 industry peers in the Metals & Mining industry. While EMX has a great health rating, there are worries on its profitability. EMX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year EMX has reported negative net income.
EMX had a positive operating cash flow in the past year.
EMX had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: EMX reported negative operating cash flow in multiple years.
EMX.CA Yearly Net Income VS EBIT VS OCF VS FCFEMX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

1.2 Ratios

EMX's Return On Assets of -2.35% is amongst the best of the industry. EMX outperforms 81.21% of its industry peers.
The Return On Equity of EMX (-3.14%) is better than 80.24% of its industry peers.
Industry RankSector Rank
ROA -2.35%
ROE -3.14%
ROIC N/A
ROA(3y)-5.04%
ROA(5y)-6.89%
ROE(3y)-7.51%
ROE(5y)-8.54%
ROIC(3y)N/A
ROIC(5y)N/A
EMX.CA Yearly ROA, ROE, ROICEMX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

1.3 Margins

EMX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMX.CA Yearly Profit, Operating, Gross MarginsEMX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K 2K

More info and screens

7

2. Health

2.1 Basic Checks

EMX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EMX has been increased compared to 1 year ago.
EMX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EMX has been reduced compared to a year ago.
EMX.CA Yearly Shares OutstandingEMX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
EMX.CA Yearly Total Debt VS Total AssetsEMX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 4.33 indicates that EMX is not in any danger for bankruptcy at the moment.
The Altman-Z score of EMX (4.33) is better than 68.00% of its industry peers.
EMX has a debt to FCF ratio of 9.03. This is a negative value and a sign of low solvency as EMX would need 9.03 years to pay back of all of its debts.
EMX's Debt to FCF ratio of 9.03 is amongst the best of the industry. EMX outperforms 91.27% of its industry peers.
EMX has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.30, EMX is doing worse than 68.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.03
Altman-Z 4.33
ROIC/WACCN/A
WACC9.52%
EMX.CA Yearly LT Debt VS Equity VS FCFEMX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

A Current Ratio of 13.15 indicates that EMX has no problem at all paying its short term obligations.
With an excellent Current ratio value of 13.15, EMX belongs to the best of the industry, outperforming 88.48% of the companies in the same industry.
EMX has a Quick Ratio of 13.15. This indicates that EMX is financially healthy and has no problem in meeting its short term obligations.
EMX has a Quick ratio of 13.15. This is amongst the best in the industry. EMX outperforms 88.48% of its industry peers.
Industry RankSector Rank
Current Ratio 13.15
Quick Ratio 13.15
EMX.CA Yearly Current Assets VS Current LiabilitesEMX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

EMX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.67%.
The Revenue for EMX has decreased by -28.20% in the past year. This is quite bad
The Revenue has been growing by 65.69% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-36.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-52.51%
Revenue 1Y (TTM)-28.2%
Revenue growth 3Y54.64%
Revenue growth 5Y65.69%
Sales Q2Q%-45.63%

3.2 Future

Based on estimates for the next years, EMX will show a very strong growth in Earnings Per Share. The EPS will grow by 53.56% on average per year.
The Revenue is expected to grow by 11.26% on average over the next years. This is quite good.
EPS Next Y-50%
EPS Next 2Y100%
EPS Next 3Y51.83%
EPS Next 5Y53.56%
Revenue Next Year-3.76%
Revenue Next 2Y-0.75%
Revenue Next 3Y2.68%
Revenue Next 5Y11.26%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
EMX.CA Yearly Revenue VS EstimatesEMX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
EMX.CA Yearly EPS VS EstimatesEMX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 -0.1 -0.15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EMX. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 61.17, which means the current valuation is very expensive for EMX.
Based on the Price/Forward Earnings ratio, EMX is valued cheaply inside the industry as 87.39% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of EMX to the average of the S&P500 Index (22.10), we can say EMX is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 61.17
EMX.CA Price Earnings VS Forward Price EarningsEMX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EMX is valued cheaper than 88.61% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EMX is valued cheaper than 91.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 72.18
EV/EBITDA 39.28
EMX.CA Per share dataEMX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

A more expensive valuation may be justified as EMX's earnings are expected to grow with 51.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y100%
EPS Next 3Y51.83%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EMX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMX ROYALTY CORP

TSX-V:EMX (3/7/2025, 7:00:00 PM)

2.52

-0.01 (-0.4%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-26 2025-03-26/bmo
Inst Owners13.79%
Inst Owner ChangeN/A
Ins Owners15.07%
Ins Owner ChangeN/A
Market Cap277.91M
Analysts84.44
Price Target4.34 (72.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.25%
PT rev (3m)11.51%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)40%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)10.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 61.17
P/S 10.36
P/FCF 72.18
P/OCF 72.18
P/B 2.37
P/tB 2.37
EV/EBITDA 39.28
EPS(TTM)-0.03
EYN/A
EPS(NY)0.04
Fwd EY1.63%
FCF(TTM)0.03
FCFY1.39%
OCF(TTM)0.03
OCFY1.39%
SpS0.24
BVpS1.06
TBVpS1.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.35%
ROE -3.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 14.36%
ROA(3y)-5.04%
ROA(5y)-6.89%
ROE(3y)-7.51%
ROE(5y)-8.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.03
Debt/EBITDA 4.92
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion 54.48%
Profit Quality N/A
Current Ratio 13.15
Quick Ratio 13.15
Altman-Z 4.33
F-Score4
WACC9.52%
ROIC/WACCN/A
Cap/Depr(3y)10.09%
Cap/Depr(5y)13.67%
Cap/Sales(3y)3.1%
Cap/Sales(5y)3.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-52.51%
EPS Next Y-50%
EPS Next 2Y100%
EPS Next 3Y51.83%
EPS Next 5Y53.56%
Revenue 1Y (TTM)-28.2%
Revenue growth 3Y54.64%
Revenue growth 5Y65.69%
Sales Q2Q%-45.63%
Revenue Next Year-3.76%
Revenue Next 2Y-0.75%
Revenue Next 3Y2.68%
Revenue Next 5Y11.26%
EBIT growth 1Y76.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year494.16%
EBIT Next 3Y100.61%
EBIT Next 5Y86.58%
FCF growth 1Y-76.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.65%
OCF growth 3YN/A
OCF growth 5YN/A